Shrimp Disease Diagnostics Market by Kit (Assay Based Kit, Rapid Testing Kit), Disease (Early Mortality Syndrome, Taura Syndrome Virus, White Spot Syndrome Virus), End User - Global Forecast 2024-2030


Attention: There is an updated edition available for this report.

Shrimp Disease Diagnostics Market by Kit (Assay Based Kit, Rapid Testing Kit), Disease (Early Mortality Syndrome, Taura Syndrome Virus, White Spot Syndrome Virus), End User - Global Forecast 2024-2030


The Shrimp Disease Diagnostics Market size was estimated at USD 443.18 million in 2023 and expected to reach USD 478.10 million in 2024, at a CAGR 7.92% to reach USD 755.83 million by 2030.

Global Shrimp Disease Diagnostics Market

Shrimp disease refers to various infectious and non-infectious conditions that affect the health, growth, and survival of shrimp in aquaculture systems. These diseases can be caused by various pathogens, such as bacteria, viruses, parasites, and fungi. The shrimp disease diagnostics technologies encompass various diagnostics tools such as morphological pathology (direct light microscopy, histopathology, electron microscopy), enhancement and bioassay methods, traditional microbiology, nucleic acid-based PCR assays, and serological methods to detect the prevalence of disease among shrimp population. The growing global demand for seafood products due to consumer preference for healthier protein sources and rising incidences of abiotic and biotic stresses and chronic diseases among the shrimp population has necessitated the deployment of shrimp disease diagnostics tools. However, the high cost of advanced diagnostic technologies may hinder the adoption of diagnostic tools among small-scale farms or developing countries. Furthermore, the lack of skilled personnel to perform complex diagnostic procedures and the absence of standardized testing protocols for shrimp disease prediction pose hurdles for the adoption of shrimp disease diagnostics strategies. To address these challenges and capitalize on existing opportunities, businesses operating within the shrimp disease diagnostics market should focus on innovation, research-driven product development, and collaboration with stakeholders across the industry. Furthermore, advancements in diagnostic technology and the utilization of nanotechnology for disease diagnosis can propel the growth and adoption of shrimp disease diagnostics.

Regional Insights

In the Americas, particularly Latin America and the Caribbean region, shrimp aquaculture is a major source of income for many coastal communities. The United States also has considerable coastal areas focused on aquaculture and shrimp production. In recent years, there has been an increased focus on implementing biosecurity measures to prevent the spread of diseases such as white spot syndrome virus (WSSV) and early mortality syndrome (EMS). There are some regional companies actively involved in research or product development related to shrimp disease diagnostics, and they offer molecular diagnostic services focused on early identification and management of pathogens affecting shrimps. Asia accounts for a large proportion of global shrimp production among China, India, Thailand, Vietnam, and Indonesia and requires proper diagnostics for this region's growing aquaculture sector. The company scenario in the Asian market is characterized by both international players providing a variety of diagnostic assays and instruments, as well as regional companies that focus on developing innovative solutions tailored to local needs. In Europe, countries, including Spain and France, emphasize biosecurity measures and strict monitoring protocols to prevent the introduction of diseases such as WSSV into their domestic farming operations. European countries contribute significantly to the development and production of advanced diagnostic tools for shrimp diseases. Some European institutions engage in research collaborations with aquaculture stakeholders from other regions to help improve diagnostics capabilities globally.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Shrimp Disease Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Shrimp Disease Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Shrimp Disease Diagnostics Market, highlighting leading vendors and their innovative profiles. These include 3 Little Fish Sdn Bhd, Amazing Biotech, Aquaintech Inc., Arachem (M) Sdn Bhd, Bioneer Corporation, Blue Aqua International Pte. Ltd., CD Genomics, China Guangzhou BioKey Healthy Technology Co. Ltd, DSM Austria GmbH, Forte Biotech, GeneReach Biotechnology Corp., GeneReach Biotechnology Corporation, Genics Pty. Ltd., Illumina, Inc., Innocreate Bioscience Co., Ltd., Lab-Ind Resource Sdn. Bhd., Laboratory Corporation of America Holdings, Mahesh Aqua Holdings (Pvt) Ltd., Mylab Discovery Solutions Pvt. Ltd., PT Riset Nusantara Genetika (Nusantics), Randox Laboratories Ltd., Reagen LLC, Ring Biotechnology Co Ltd., Speedy Assay Sdn. Bhd., SUREBIO, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Shrimp Disease Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Kit
Assay Based Kit
Rapid Testing Kit
Disease
Early Mortality Syndrome
Taura Syndrome Virus
White Spot Syndrome Virus
Yellow Head or Gill Associated Virus
End User
Aquaculture & Marine Laboratories
Education & Research Institutes
Fisheries
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Shrimp Disease Diagnostics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Shrimp Disease Diagnostics Market?
3. What are the technology trends and regulatory frameworks in the Shrimp Disease Diagnostics Market?
4. What is the market share of the leading vendors in the Shrimp Disease Diagnostics Market?
5. Which modes and strategic moves are suitable for entering the Shrimp Disease Diagnostics Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Shrimp Disease Diagnostics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing shrimp production and export activities worldwide
5.1.1.2. Public-private awareness initiatives and welfare projects to tackle shrimp diseases
5.1.1.3. Regulations for quality shrimp farming and need for efficient disease detection tools
5.1.2. Restraints
5.1.2.1. Complex testing procedures and need for trained personnel
5.1.3. Opportunities
5.1.3.1. Advancements in shrimp diagnostics technologies and rapid testing methods
5.1.3.2. New investments in expansion of shrimp farming activities
5.1.4. Challenges
5.1.4.1. Limitations associated with false positives and inaccuracy of shrimp disease diagnostics
5.2. Market Segmentation Analysis
5.2.1. Kit: Growing adoption of rapid testing kits for quick and easy detection of pathogens
5.2.2. Disease: Highly contagious nature of white spot syndrome virus (WSSV) necessitating quality PCR and histological tests
5.2.3. End User: Rising incidences of shrimp disease outbreaks in fisheries necessitating deployment of shrimp disease diagnostics strategies
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Shrimp Disease Diagnostics Market, by Kit
6.1. Introduction
6.2. Assay Based Kit
6.3. Rapid Testing Kit
7. Shrimp Disease Diagnostics Market, by Disease
7.1. Introduction
7.2. Early Mortality Syndrome
7.3. Taura Syndrome Virus
7.4. White Spot Syndrome Virus
7.5. Yellow Head or Gill Associated Virus
8. Shrimp Disease Diagnostics Market, by End User
8.1. Introduction
8.2. Aquaculture & Marine Laboratories
8.3. Education & Research Institutes
8.4. Fisheries
9. Americas Shrimp Disease Diagnostics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Shrimp Disease Diagnostics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Shrimp Disease Diagnostics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Agreement, Collaboration, & Partnership
12.3.1.1. Aquatreck Signs Research Agreement to Develop Diagnostic Services for Fish Farms
12.3.2. Investment & Funding
12.3.2.1. US Project to Develop Low-Cost White Spot Test for Shrimp Farmers
12.3.2.2. ViAqua Therapeutics Secures Funding for RNA-based Aquaculture Disease Management
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. 3 Little Fish Sdn Bhd
13.1.2. Amazing Biotech
13.1.3. Aquaintech Inc.
13.1.4. Arachem (M) Sdn Bhd
13.1.5. Bioneer Corporation
13.1.6. Blue Aqua International Pte. Ltd.
13.1.7. CD Genomics
13.1.8. China Guangzhou BioKey Healthy Technology Co. Ltd
13.1.9. DSM Austria GmbH
13.1.10. Forte Biotech
13.1.11. GeneReach Biotechnology Corp.
13.1.12. GeneReach Biotechnology Corporation
13.1.13. Genics Pty. Ltd.
13.1.14. Illumina, Inc.
13.1.15. Innocreate Bioscience Co., Ltd.
13.1.16. Lab-Ind Resource Sdn. Bhd.
13.1.17. Laboratory Corporation of America Holdings
13.1.18. Mahesh Aqua Holdings (Pvt) Ltd.
13.1.19. Mylab Discovery Solutions Pvt. Ltd.
13.1.20. PT Riset Nusantara Genetika (Nusantics)
13.1.21. Randox Laboratories Ltd.
13.1.22. Reagen LLC
13.1.23. Ring Biotechnology Co Ltd.
13.1.24. Speedy Assay Sdn. Bhd.
13.1.25. SUREBIO
13.1.26. Thermo Fisher Scientific Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. SHRIMP DISEASE DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. SHRIMP DISEASE DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2023 VS 2030 (%)
FIGURE 8. SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
FIGURE 10. SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. SHRIMP DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. SHRIMP DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings